drugset / Trial / NCT00714103
8-Chloro-Adenosine in Chronic Lymphocytic Leukemia
Phase 1
Completed
11 enrolled
M.D. Anderson Cancer Center
FDA Office of Orphan Products Development · collabNational Cancer Institute (NCI) · collab
NaSingle-groupOpen-labelTreatment
Summary
The goal of this clinical research study is to find the highest safe dose of the drug 8-chloro-adenosine that can be given in the treatment of chronic lymphocytic leukemia (CLL). Another goal is to learn how effective the drug is at treating leukemia.
Timeline
- Start
- 2008-06
- Primary completion
- 2016-10
- Completion
- 2016-10
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | 8-Chloroadenosine | Small molecule | 45 mg/m2 | Intravenous |